We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.64 | 18.23% | 4.15 | 3.50 | 4.80 | - | 423,867 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.80 | 10.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/4/2023 11:24 | Aye. I remember Richard claims he gave a "caveat". I don't remember it saying "Of course it is entirely possible that after 20 years not a single one will have been achieved". Already licensed :- assumed will achieve all of rated royalty Stroke PoC post #13,776 gross *SP at $265m, *SP 12% royalty $32m BSE, post #13,533 gross *PRM $490m, royalty *=Biosite? 12% $26m BSE, rest of world, #13,667, I estimated 3 times Europe $78m Total for already licensed - $136m Ready for commercialisation :- assumed will achieve two thirds of royalty Not actually a test– Sensitizer gross *Chataway £50m *FT 20% royalty £10m Stroke HTS post #13,776 gross *SP at $2,385m, *?same as PoC royalty $286m CJD in humans – small market for PoC; HTS will not be valuable unless a cure for CJD is found CJD blood HTS post 13,021, gross *goatherd $675m, *goatherd 12% royalty $81m Heart Transplant rejection post 12,414, gross *SP $52m, *goatherd 12% royalty $6m; this might extend to kidney transplants later Ischaemic/haemorrhag Total for ready for commercialisation - $391m two thirds is $260m ”working on”:- assumed will achieve one third of royalty Parkinson’s disease #15,294, gross *goatherd $5.75m, *goatherd 12% royalty $0.7m Pain – I have not been able to quantify this. Lung cancer #15,312, gross *goatherd $3150m *goatherd 15% royalty $472m Colon cancer, post #12,727, gross [assuming $20/test] *goatherd $1,640m, *goatherd 12%, royalty $200m Neuroblastoma #15,274 gross *goatherd $80m, *goatherd 12% royalty $9m. Breast cancer, #13,891m gross *goatherd $2,220m, *goatherd 12%, royalty $266m Pancreatic cancer #15,286. gross *goatherd $3000m, *goatherd 12% royalty $360m. | jeffian | |
11/4/2023 11:21 | I often find me’sen wondering if it was old slippery that taught goatherd the friction free, Teflon coated, olive oil shouldered approach or was it vice versa? In other words, who was the PRM freebb Mr Miyagi and who is grasshopper? | monte1 | |
11/4/2023 11:01 | Ah, you and timelines, eh, Richard? You can never be 'wrong' because time is infinite, of course. This year, next year, sometime, never. This year is the 20th Anniversary of the infamous 'guesstimates'...... | jeffian | |
11/4/2023 10:51 | That is what I was told, authoritatively. I believed it then, and I believe it now - I did say "soonish", and, in my vocabulary "soonish" could be six months, perhaps even nine. BUT, if the new trials indicate that there was insufficient evidence for the CE test (which it is unlikely anyone would have realised at that time) then clearly things would take longer. | goatherd | |
11/4/2023 09:15 | goatherd 1 Feb '23 - 17:17 - 59390 of 59409 0 3 0 Yes, the stroke test IS coming. Soon (or soonish, perhaps). It has passed all trials, but still awaits CE. | elpirata | |
11/4/2023 07:26 | You or CJP ?? | peverill | |
10/4/2023 21:18 | Prove it then. | goatherd | |
10/4/2023 21:17 | Christopher Pearce allegedly lied too and will be exposed I hear | canaletto | |
10/4/2023 21:11 | You do lie Goatherd | canaletto | |
10/4/2023 10:47 | I couldn’t possibly say on a freebb matey. | monte1 | |
10/4/2023 10:04 | Is pools a farmer also or a secondary. | peverill | |
10/4/2023 09:05 | The old farmers club? | monte1 | |
10/4/2023 08:33 | I find it amazing how these idiots passing on info from their sources,manage to bump into other idiots who haven't got a clue either,is there an idiot club for them all somewhere. | peverill | |
09/4/2023 12:38 | quite so pev, Thought for the day pools2 14 Nov '22 - 12:45 - 91713 of 92220 0 8 0 Just sitting having a coffee at Medica, Dusseldorf. Just been told by Randox that their Stroke biochip test will be released imminently (but gave no date) :) | elpirata | |
09/4/2023 11:28 | If only that were the case eh? | monte1 | |
09/4/2023 10:58 | I only started into shares in 1999, so not 27 years, yet. Surely nobody should be blamed for passing on thoughts; provided, of course, that they are honest and not self-serving? | goatherd | |
09/4/2023 09:03 | You deserve to be rewarded for your 27 years of optimism about PRM, or, you deserve nothing but misery for passing on your optimistic thoughts to the BB. Not sure which. | dominiccummings | |
08/4/2023 18:57 | Or, could be, 20p a share if Randox pull their fingers out. Or Galaxy do. Or even if the new Alzheimer's patent bears fruit. | goatherd | |
08/4/2023 17:46 | The only way you are going to recoup a penny here is if you apply for a job at PRM.They are at this 27 years and still can't get it right.There is no white rabbit coming,no multi million contracts,just a slow burn from what amounts to a cottage business to keep CJP out of the house through the day,will probably be 2p a share come year end. | peverill |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions